Akso Health Group ADR (AHG) revenue breakdown

Healthcare · Medical Distribution · Market cap $960M

By product, Revenue is the largest at 100% of fiscal 2026 revenue, growing 23% a year over 4 years.

Revenue by product

Fiscal years, as Akso Health Group ADR reports them in its 10-K filings; fiscal 2026 total $14M.

Products2017201820192020202120222023202420252026Share
Revenue—————$6M$13M$2M$15M$14M 100%
Loan facilitation service$26M$118M$67M——————— —
Post-origination service$1M$4M$11M——————— —
Recommendation service——$858,796$4M—————— —
Loan management service$3M————————— —
Loan management service—$508,948———————— —
Interest income—$590,122$4M$3M$2M$215,393———— —
Other———$161,538—————— —
Commission service————$82,054$96,332———— —
Others$59,756$21,434$1,491——————— —
Tax and surcharges——————-$4,964-$2,459-$3,824-$3,159 -0%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for AHG.
Open AHG in Investingly

Questions

Where does Akso Health Group ADR make its money?

In fiscal 2026, by product: Revenue $14M.

From Akso Health Group ADR's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.